These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
509 related items for PubMed ID: 9102227
1. Cholecystokinin(CCK)-A and CCK-B/gastrin receptors in human tumors. Reubi JC, Schaer JC, Waser B. Cancer Res; 1997 Apr 01; 57(7):1377-86. PubMed ID: 9102227 [Abstract] [Full Text] [Related]
2. Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies. Béhé M, Behr TM. Biopolymers; 2002 Apr 01; 66(6):399-418. PubMed ID: 12658727 [Abstract] [Full Text] [Related]
4. Cholecystokinin-B/gastrin receptor binding peptides: preclinical development and evaluation of their diagnostic and therapeutic potential. Behr TM, Béhé M, Angerstein C, Gratz S, Mach R, Hagemann L, Jenner N, Stiehler M, Frank-Raue K, Raue F, Becker W. Clin Cancer Res; 1999 Oct 01; 5(10 Suppl):3124s-3138s. PubMed ID: 10541353 [Abstract] [Full Text] [Related]
5. Unexpected high incidence of cholecystokinin-B/gastrin receptors in human medullary thyroid carcinomas. Reubi JC, Waser B. Int J Cancer; 1996 Sep 04; 67(5):644-7. PubMed ID: 8782652 [Abstract] [Full Text] [Related]
6. Radiolabeled peptides for targeting cholecystokinin-B/gastrin receptor-expressing tumors. Behr TM, Jenner N, Béhé M, Angerstein C, Gratz S, Raue F, Becker W. J Nucl Med; 1999 Jun 04; 40(6):1029-44. PubMed ID: 10452322 [Abstract] [Full Text] [Related]
7. Characterization of cholecystokinin receptors and messenger RNA expression in rat pancreas: evidence for expression of cholecystokinin-A receptors but not cholecystokinin-B (gastrin) receptors. Zhou W, Povoski SP, Bell RH. J Surg Res; 1995 Mar 04; 58(3):281-9. PubMed ID: 7533864 [Abstract] [Full Text] [Related]
8. Novel expression of gastrin (cholecystokinin-B) receptors in azaserine-induced rat pancreatic carcinoma: receptor determination and characterization. Zhou W, Povoski SP, Longnecker DS, Bell RH. Cancer Res; 1992 Dec 15; 52(24):6905-11. PubMed ID: 1458479 [Abstract] [Full Text] [Related]
9. Cholecystokinin-B/Gastrin receptor-targeting peptides for staging and therapy of medullary thyroid cancer and other cholecystokinin-B receptor-expressing malignancies. Behr TM, Béhé MP. Semin Nucl Med; 2002 Apr 15; 32(2):97-109. PubMed ID: 11965605 [Abstract] [Full Text] [Related]
10. CCKA and CCKB receptors are expressed in small cell lung cancer lines and mediate Ca2+ mobilization and clonal growth. Sethi T, Herget T, Wu SV, Walsh JH, Rozengurt E. Cancer Res; 1993 Nov 01; 53(21):5208-13. PubMed ID: 8221657 [Abstract] [Full Text] [Related]
11. Bombesin receptor subtypes in human cancers: detection with the universal radioligand (125)I-[D-TYR(6), beta-ALA(11), PHE(13), NLE(14)] bombesin(6-14). Reubi JC, Wenger S, Schmuckli-Maurer J, Schaer JC, Gugger M. Clin Cancer Res; 2002 Apr 01; 8(4):1139-46. PubMed ID: 11948125 [Abstract] [Full Text] [Related]
12. High gastrin and cholecystokinin (CCK) gene expression in human neuronal, renal, and myogenic stem cell tumors: comparison with CCK-A and CCK-B receptor contents. Schaer JC, Reubi JC. J Clin Endocrinol Metab; 1999 Jan 01; 84(1):233-9. PubMed ID: 9920090 [Abstract] [Full Text] [Related]
13. Preclinical and initial clinical evaluation of 111In-labeled nonsulfated CCK8 analog: a peptide for CCK-B receptor-targeted scintigraphy and radionuclide therapy. de Jong M, Bakker WH, Bernard BF, Valkema R, Kwekkeboom DJ, Reubi JC, Srinivasan A, Schmidt M, Krenning EP. J Nucl Med; 1999 Dec 01; 40(12):2081-7. PubMed ID: 10616889 [Abstract] [Full Text] [Related]
14. [Gastrin-17 and G17-gly induce proliferation of LoVo cells through the CCK B/gastrin receptor]. Artru P, Attoub S, Levasseur S, Lewin MJ, Bado A. Gastroenterol Clin Biol; 1998 Dec 01; 22(6-7):607-12. PubMed ID: 9762332 [Abstract] [Full Text] [Related]
15. Unsulfated DTPA- and DOTA-CCK analogs as specific high-affinity ligands for CCK-B receptor-expressing human and rat tissues in vitro and in vivo. Reubi JC, Waser B, Schaer JC, Laederach U, Erion J, Srinivasan A, Schmidt MA, Bugaj JE. Eur J Nucl Med; 1998 May 01; 25(5):481-90. PubMed ID: 9575243 [Abstract] [Full Text] [Related]
16. Identification of cholecystokinin-B/gastrin receptor domains that confer high gastrin affinity: utilization of a novel Xenopus laevis cholecystokinin receptor. Schmitz F, Pratt DS, Wu MJ, Kolakowski LF, Beinborn M, Kopin AS. Mol Pharmacol; 1996 Aug 01; 50(2):436-41. PubMed ID: 8700154 [Abstract] [Full Text] [Related]
17. High affinity binding of cholecystokinin to small cell lung cancer cells. Yoder DG, Moody TW. Peptides; 1987 Aug 01; 8(1):103-7. PubMed ID: 3033616 [Abstract] [Full Text] [Related]
18. Expression of cholecystokinin-B/gastrin receptors in medullary thyroid cancer. Amiri-Mosavi A, Ahlman H, Tisell LE, Wängberg B, Kölby L, Forssell-Aronsson E, Lundberg PA, Lindstedt G, Nilsson O. Eur J Surg; 1999 Jul 01; 165(7):628-31. PubMed ID: 10452255 [Abstract] [Full Text] [Related]
19. Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin. Reubi JC, Läderach U, Waser B, Gebbers JO, Robberecht P, Laissue JA. Cancer Res; 2000 Jun 01; 60(11):3105-12. PubMed ID: 10850463 [Abstract] [Full Text] [Related]
20. Gastrin stimulates growth of human colon cancer cells via a receptor other than CCK-A or CCK-B. Bold RJ, Ishizuka J, Townsend CM, Thompson JC. Biochem Biophys Res Commun; 1994 Aug 15; 202(3):1222-6. PubMed ID: 8060296 [Abstract] [Full Text] [Related] Page: [Next] [New Search]